keyword
https://read.qxmd.com/read/38646521/immunoglobulins-and-serum-proteins-impair-anti-tumor-nk-cell-effector-functions-in-malignant-ascites
#1
JOURNAL ARTICLE
Antonio Hrvat, Sonja Benders, Rainer Kimmig, Sven Brandau, Nina Mallmann-Gottschalk
INTRODUCTION: Malignant ascites indicates ovarian cancer progression and predicts poor clinical outcome. Various ascites components induce an immunosuppressive crosstalk between tumor and immune cells, which is poorly understood. In our previous study, imbalanced electrolytes, particularly high sodium content in malignant ascites, have been identified as a main immunosuppressive mechanism that impaired NK and T-cell activity. METHODS: In the present study, we explored the role of high concentrations of ascites proteins and immunoglobulins on antitumoral NK effector functions...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38626767/structural-basis-for-the-immune-recognition-and-selectivity-of-the-immune-receptor-pvrig-for-ligand-nectin-2
#2
JOURNAL ARTICLE
Songtao Hu, Pu Han, Meiyu Wang, Xiaoqing Cao, Hao Liu, Shuailong Zhang, Shuijun Zhang, Jun Liu, Yi Han, Jinhe Xiao, Qiang Chen, Kai Miao, Jianxun Qi, Shuguang Tan, George Fu Gao, Han Wang
Nectin and nectin-like (Necl) co-receptor axis, comprised of receptors DNAM-1, TIGIT, CD96, PVRIG, and nectin/Necl ligands, is gaining prominence in immuno-oncology. Within this axis, the inhibitory receptor PVRIG recognizes Nectin-2 with high affinity, but the underlying molecular basis remains unknown. By determining the crystal structure of PVRIG in complex with Nectin-2, we identified a unique CC' loop in PVRIG, which complements the double-lock-and-key binding mode and contributes to its high affinity for Nectin-2...
April 8, 2024: Structure
https://read.qxmd.com/read/38619282/themis2-impairs-antitumor-activity-of-nk-cells-by-suppressing-activating-nk-receptor-signaling
#3
JOURNAL ARTICLE
Elfira Amalia Deborah, Tsukasa Nabekura, Kazuko Shibuya, Akira Shibuya
NK cells are cytotoxic innate lymphocytes that play a critical role in antitumor immunity. NK cells recognize target cells by using a repertoire of activating NK receptors and exert the effector functions. Although the magnitude of activation signals through activating NK receptors controls NK cell function, it has not been fully understood how these activating signals are modulated in NK cells. In this study, we found that a scaffold protein, THEMIS2, inhibits activating NK receptor signaling. Overexpression of THEMIS2 attenuated the effector function of human NK cells, whereas knockdown of THEMIS2 enhanced it...
April 15, 2024: Journal of Immunology
https://read.qxmd.com/read/38602695/delta-one-t-cells-recognize-aml-via-dnam-1
#4
EDITORIAL
Dieter Kabelitz
No abstract text is available yet for this article.
April 11, 2024: Blood
https://read.qxmd.com/read/38592213/exercise-induced-%C3%AE-2-adrenergic-receptor-activation-enhances-the-anti-leukemic-activity-of-expanded-%C3%AE-%C3%AE-t-cells-via-dnam-1-upregulation-and-pvr-nectin-2-recognition
#5
JOURNAL ARTICLE
Forrest L Baker, Kyle A Smith, Preetesh L Mylabathula, Tiffany M Zuniga, Douglass M Diak, Helena Batatinha, Grace M Niemiro, Michael D Seckeler, Charles R Pedlar, Daniel P O'Connor, Jamie N Colombo, Emmanuel Katsanis, Richard J Simpson
Exercise mobilizes cytotoxic lymphocytes to blood which may allow superior cell products to be manufactured for cancer therapy. Gamma-Delta (γδ) T-cells have shown promise for treating solid tumors, but there is a need to increase their potency against hematologic malignancies. Here, we show that human γδ T-cells mobilized to blood in response to just 20-minutes of graded exercise have surface phenotypes and transcriptomic profiles associated with cytotoxicity, adhesion, migration and cytokine signaling...
April 9, 2024: Cancer Res Commun
https://read.qxmd.com/read/38521068/the-central-role-of-natural-killer-cells-in-mediating-acute-myocarditis-after-mrna-covid-19-vaccination
#6
JOURNAL ARTICLE
Hing Wai Tsang, Mike Yat Wah Kwan, Gilbert T Chua, Sabrina Siu Ling Tsao, Joshua Sung Chih Wong, Keith Tsz Suen Tung, Godfrey Chi Fung Chan, Kelvin Kai Wang To, Ian Chi Kei Wong, Wing Hang Leung, Patrick Ip
BACKGROUND: Vaccine-related acute myocarditis is recognized as a rare and specific vaccine complication following mRNA-based COVID-19 vaccinations. The precise mechanisms remain unclear. We hypothesized that natural killer (NK) cells play a central role in its pathogenesis. METHODS: Samples from 60 adolescents with vaccine-related myocarditis were analyzed, including pro-inflammatory cytokines, cardiac troponin T, genotyping, and immunophenotyping of the corresponding activation subsets of NK cells, monocytes, and T cells...
March 15, 2024: Med
https://read.qxmd.com/read/38516860/helicobacter-pylori-enhances-hla-c-expression-in-the-human-gastric-adenocarcinoma-cells-ags-and-can-protect-them-from-the-cytotoxicity-of-natural-killer-cells
#7
JOURNAL ARTICLE
Etikala Apoorva, Rini Jacob, Desirazu N Rao, Santosh Kumar
Helicobacter pylori (H. pylori) seems to play causative roles in gastric cancers. H. pylori has also been detected in established gastric cancers. How the presence of H. pylori modulates immune response to the cancer is unclear. The cytotoxicity of natural killer (NK) cells, toward infected or malignant cells, is controlled by the repertoire of activating and inhibitory receptors expressed on their surface. Here, we studied H. pylori-induced changes in the expression of ligands, of activating and inhibitory receptors of NK cells, in the gastric adenocarcinoma AGS cells, and their impacts on NK cell responses...
2024: Helicobacter
https://read.qxmd.com/read/38484189/a-temporal-developmental-map-separates-human-nk-cells-from-non-cytotoxic-ilcs-through-clonal-and-single-cell-analysis
#8
JOURNAL ARTICLE
Dang Nghiem Vo, Ouyang Yuan, Minoru Kanaya, Gladys Telliam-Dushime, Hongzhe Li, Olga Kotova, Emel Caglar, Kristian Honnens de Lichtenberg, Shamim Herbert Rahman, Shamit Soneji, Stefan Scheding, David Bryder, Karl-Johan Malmberg, Ewa Sitnicka
Natural Killer (NK) cells represent the cytotoxic member within the innate lymphoid cell (ILC) family that are important against viral infections and cancer. While the NK cell emergence from hematopoietic stem and progenitor cells through multiple intermediate stages and the underlying regulatory gene network has been extensively studied in mouse, this process is not well characterized in human. Here, using a temporal in vitro model to reconstruct the developmental trajectory of NK lineage, we identified an ILC-restricted oligo-potent Stage 3a CD34-CD117+CD161+CD45RA+CD56- progenitor population, that exclusively gave rise to CD56-expressing ILCs in vitro...
March 14, 2024: Blood Advances
https://read.qxmd.com/read/38437507/cd155-pvr-determines-acute-myeloid-leukemia-targeting-by-delta-one-t-cells
#9
JOURNAL ARTICLE
Sofia Mensurado, Ana Carolina Condeço, Diego Sánchez-Martínez, Sara Shirley, Rui M L Coelho, Néstor Tirado, Meritxell Vinyoles, Rafael Blanco-Domínguez, Leandro Barros, Beatriz Galvão, Noélia Custódio, Maria Gomes da Silva, Pablo Menendez, Bruno Silva-Santos
Relapsed or refractory Acute Myeloid Leukemia (AML) remains a major therapeutic challenge. We have recently developed a V1+  T-cell-based product for adoptive immunotherapy, named Delta One T (DOT) cells, and demonstrated their cytolytic capacity to eliminate AML cell lines and primary blasts in vitro and in vivo. However, the molecular mechanisms responsible for the broad DOT-cell recognition of AML cells remain poorly understood. Here we dissected the role of NK-cell receptor ligands in AML cell recognition by DOT-cells...
February 16, 2024: Blood
https://read.qxmd.com/read/38390333/cd34-dnam-1-bright-cxcr4-haemopoietic-precursors-circulate-after-chemotherapy-seed-lung-tissue-and-generate-functional-innate-like-t-cells-and-nk-cells
#10
JOURNAL ARTICLE
Carola Perrone, Federica Bozzano, Maria Giovanna Dal Bello, Genny Del Zotto, Francesca Antonini, Enrico Munari, Enrico Maggi, Francesca Moretta, Alireza Hajabbas Farshchi, Gianluca Pariscenti, Marco Tagliamento, Carlo Genova, Lorenzo Moretta, Andrea De Maria
BACKGROUND: There is little information on the trajectory and developmental fate of Lin- CD34+ DNAM-1bright CXCR4+ progenitors exiting bone marrow during systemic inflammation. OBJECTIVE: To study Lin- CD34+ DNAM-1bright CXCR4+ cell circulation in cancer patients, to characterize their entry into involved lung tissue and to characterize their progenies. METHODS: Flow cytometric analysis of PBMC from 18 patients with lung cancer on samples collected immediately before the first and the second treatment was performed to study Lin- CD34+ DNAM-1bright CXCR4+ precursors...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38289706/essential-role-of-cd155-glycosylation-in-functional-binding-to-dnam-1-on-natural-killer-cells
#11
JOURNAL ARTICLE
Saeko Tahara, Genki Okumura, Tomohei Matsuo, Akira Shibuya, Kazuko Shibuya
CD155 is highly expressed on tumor cells and augments or inhibits the cytotoxic activities of natural killer (NK) cells and T cells through its receptor ligands DNAM-1 and T cell immunoglobulin immunoreceptor tyrosine-based inhibitory motif domain (TIGIT), respectively. Although CD155 is heavily glycosylated, the role of glycosylation of CD155 in the cytotoxic activity of effector lymphocytes remains unknown. Here, we show that the N-linked glycosylation at residue 105 (N105 glycosylation) in the first immunoglobulin-like domain of CD155 is involved in the binding of CD155 to both DNAM-1 and TIGIT...
January 30, 2024: International Immunology
https://read.qxmd.com/read/38211590/therapeutic-application-of-human-type-2-innate-lymphoid-cells-via-induction-of-granzyme-b-mediated-tumor-cell-death
#12
JOURNAL ARTICLE
Zhenlong Li, Rui Ma, Hejun Tang, Jiamin Guo, Zahir Shah, Jianying Zhang, Ningyuan Liu, Shuai Cao, Guido Marcucci, David Artis, Michael A Caligiuri, Jianhua Yu
The therapeutic potential for human type 2 innate lymphoid cells (ILC2s) has been underexplored. Although not observed in mouse ILC2s, we found that human ILC2s secrete granzyme B (GZMB) and directly lyse tumor cells by inducing pyroptosis and/or apoptosis, which is governed by a DNAM-1-CD112/CD155 interaction that inactivates the negative regulator FOXO1. Over time, the high surface density expression of CD155 in acute myeloid leukemia cells impairs the expression of DNAM-1 and GZMB, thus allowing for immune evasion...
February 1, 2024: Cell
https://read.qxmd.com/read/38191799/fgl2-promotes-tumour-growth-and-attenuates-infiltration-of-activated-immune-cells-in-melanoma-and-ovarian-cancer-models
#13
JOURNAL ARTICLE
Kristianne J C Galpin, Galaxia M Rodriguez, Vincent Maranda, David P Cook, Elizabeth Macdonald, Humaira Murshed, Shan Zhao, Curtis W McCloskey, Andrzej Chruscinski, Gary A Levy, Michele Ardolino, Barbara C Vanderhyden
The tumour microenvironment is infiltrated by immunosuppressive cells, such as regulatory T cells (Tregs), which contribute to tumour escape and impede immunotherapy outcomes. Soluble fibrinogen-like protein 2 (sFGL2), a Treg effector protein, inhibits immune cell populations, via receptors FcγRIIB and FcγRIII, leading to downregulation of CD86 in antigen presenting cells and limiting T cell activation. Increased FGL2 expression is associated with tumour progression and poor survival in several different cancers, such as glioblastoma multiforme, lung, renal, liver, colorectal, and prostate cancer...
January 8, 2024: Scientific Reports
https://read.qxmd.com/read/38191686/distinct-peripheral-t-cell-and-nk-cell-profiles-in-hgbl-myc-bcl2-versus-dlbcl-nos-patients
#14
JOURNAL ARTICLE
A Vera de Jonge, Carolien Duetz, Wassilis S C Bruins, Charlotte L B M Korst, Rosa Rentenaar, Meliha Cosovic, Merve Eken, Inoka Twickler, Marcel Nijland, Marjolein W M van der Poel, Koen de Heer, Clara P W Klerk, Leonie Strobbe, Margriet Oosterveld, Rinske Boersma, Harry R Koene, Margaretha G M Roemer, Erik van Werkhoven, Martine E D Chamuleau, Tuna Mutis
High-grade B-cell lymphoma patients with MYC and BCL2 rearrangements (HGBL-MYC/BCL2) respond poorly to immuno-chemotherapy compared to diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) patients without a MYC rearrangement. This suggests a negative impact of lymphoma-intrinsic MYC on the immune system. To investigate this, we compared circulating T-cells and NK-cells of HGBL-MYC/BCL2 patients (n=66), DLBCL NOS patients (n=53) and age-matched healthy donors (HDs, n=16) by flow cytometry and performed proliferation, cytokine production and cytotoxicity assays...
January 8, 2024: Blood Advances
https://read.qxmd.com/read/38029341/the-power-of-three-nanomaterials-for-natural-killer-nk-cell-immunoengineering-maximize-their-potency-if-they-exploit-multireceptor-stimulation
#15
JOURNAL ARTICLE
Helena Dodd, Nadia Guerra, Iain E Dunlop
Many emerging cancer treatments are immunotherapies that modulate Natural Killer- (NK) or T cell activation, posing a challenge to develop immunoengineering nanomaterials that improve on the performance of molecular reagents. In physiological activation, multiple immunoreceptors signal in consort, however current biomaterials do not replicate this. Here, we create for the first time NK cell activating bionanomaterials that stimulate >2 immunoreceptors. We exploit nanoclusters of monoclonal antibodies (mAb), templated by nanoscale graphene oxide sheets (NGO) (∼75 nm size)...
November 29, 2023: Advanced Healthcare Materials
https://read.qxmd.com/read/37991420/analysis-of-butyrophilin-mediated-activation-of-%C3%AE-%C3%AE-t-cells-from-human-spleen
#16
JOURNAL ARTICLE
Chunyan Wang, Anne Y Lai, Dana C Baiu, Kelsey A Smith, Jon S Odorico, Keith Wilson, Taylor Schreiber, Suresh de Silva, Jenny E Gumperz
There is considerable interest in therapeutically engaging human γδ T cells. However, due to the unique TCRs of human γδ T cells, studies from animal models have provided limited directly applicable insights, and human γδ T cells from key immunological tissues remain poorly characterized. In this study, we investigated γδ T cells from human spleen tissue. Compared to blood, where Vδ2+Vγ9+ T cells are the dominant subset, splenic γδ T cells included a variety of TCR types, with Vδ1+ T cells typically being the most frequent...
November 22, 2023: Journal of Immunology
https://read.qxmd.com/read/37886562/nk-receptors-replace-cd28-as-the-dominant-source-of-signal-2-for-cognate-recognition-of-cancer-cells-by-taa-specific-effector-cd8-t-cells
#17
Pawel Kalinski, Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy Bonura, Henry Withers, Mark Long, Colin Chavel, Scott Olejniczak, Hans Minderman, Robert Edwards, Walter Storkus, Pedro Romero
CD28-driven "signal 2" is critical for naïve CD8 + T cell responses to dendritic cell (DC)-presented weak antigens, including non-mutated tumor-associated antigens (TAAs). However, it is unclear how DC-primed cytotoxic T lymphocytes (CTLs) respond to the same TAAs presented by cancer cells which lack CD28 ligands. Here, we show that NK receptors (NKRs) DNAM-1 and NKG2D replace CD28 during CTL re-activation by cancer cells presenting low levels of MHC I/TAA complexes, leading to enhanced proximal TCR signaling, immune synapse formation, CTL polyfunctionality, release of cytolytic granules and antigen-specific cancer cell killing...
October 19, 2023: Research Square
https://read.qxmd.com/read/37760586/dysregulation-of-dnam-1-mediated-nk-cell-anti-cancer-responses-in-the-tumor-microenvironment
#18
REVIEW
Rossella Paolini, Rosa Molfetta
NK cells play a pivotal role in anti-cancer immune responses, thanks to the expression of a wide array of inhibitory and activating receptors that regulate their cytotoxicity against transformed cells while preserving healthy cells from lysis. However, NK cells exhibit severe dysfunction in the tumor microenvironment, mainly due to the reduction of activating receptors and the induction or increased expression of inhibitory checkpoint receptors. An activating receptor that plays a central role in tumor recognition is the DNAM-1 receptor...
September 18, 2023: Cancers
https://read.qxmd.com/read/37756440/activation-of-cd8-t-cells-in-copd-lung
#19
JOURNAL ARTICLE
Ana B Villaseñor-Altamirano, Dhawal Jain, Yunju Jeong, Jaivardhan A Menon, Mari Kamiya, Hibah Haider, Reshmi Manandhar, Muhammad Dawood Amir Sheikh, Humra Athar, Louis T Merriam, Min Hyung Ryu, Takanori Sasaki, Peter J Castaldi, Deepak A Rao, Lynette M Sholl, Marina Vivero, Craig P Hersh, Xiaobo Zhou, Justus Veerkamp, Jeong H Yun, Edy Y Kim
RATIONALE: Despite the importance of inflammation in chronic obstructive pulmonary disease (COPD), the immune cell landscape in the lung tissue of patients with mild-moderate disease has not been well characterized at the single-cell and molecular level. OBJECTIVE: To define the immune cell landscape in lung tissue from patients with mild-moderate COPD at single-cell resolution. METHODS: We performed single-cell transcriptomic (RNA-seq), proteomic (CITE-seq), and T cell receptor repertoire analysis on lung tissue from patients with mild-moderate COPD (n=5, GOLD I or II), emphysema without airflow obstruction (n=5), end-stage COPD (n=2), control (n=6), or donors (n=4)...
September 27, 2023: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/37738462/nkg2a-discriminates-natural-killer-cells-with-a-suppressed-phenotype-in-pediatric-acute-leukemia
#20
JOURNAL ARTICLE
Aina Ulvmoen, Victor Greiff, Anne G Bechensteen, Marit Inngjerdingen
NK cells are important for early tumor immune surveillance. In patients with hematological cancers, NK cells are generally functional deficient and display dysregulations in their receptor repertoires. Acute leukemia is the most common cancer in children, and we here performed a comparative phenotypic profiling of NK cells from pre-B cell acute lymphoblastic leukemia (BCP-ALL) patients to identify aberrant NK cell phenotypes. NK cell phenotypes, maturation, and function were analyzed in matched bone marrow and blood NK cells from BCP-ALL patients at diagnosis, during treatment, and at end of treatment and compared to age-matched pediatric controls...
September 21, 2023: Journal of Leukocyte Biology
keyword
keyword
65569
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.